Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | BASF SE | 518 |
| 2 | Theravance Biopharma Inc | 51 |
| 3 | University of California | 34 |
| 4 | Celanese Corp | 29 |
| 5 | LG Chem Ltd | 25 |
| 6 | Zeon Corp | 21 |
| 7 | Sanofi SA | 20 |
| 8 | Centre National de la Recherche Scientifique | 19 |
| 9 | Novartis AG | 18 |
| 10 | Wacker Chemie AG | 18 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | B01D | 475 | |
| 2 | Y02E | Climate change mitigation: energy | 446 |
| 3 | B01J | Chemical/physical processes (e.g. catalysts) | 401 |
| 4 | H01M | Batteries and accumulators | 373 |
| 5 | C08G | Polymers from non-vinyl bonds (e.g. polyamides, polyesters) | 363 |
| 6 | Y02P | Climate change mitigation: production | 352 |
| 7 | C07D | Heterocyclic compounds | 344 |
| 8 | A61P | Therapeutic activity (drug indications) | 307 |
| 9 | C08J | Working-up of plastics | 269 |
| 10 | A61K | Medicinal preparations | 244 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| The Sm MOF materials and preparation method constructed using 3,5 pyrazoles dicarboxylic acids as part | 2018 | 6 | |
| A kind of Nd MOF materials constructed using 3,5 pyrazoles dicarboxylic acids as part and preparation method | 2018 | 5 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | A.M. Beatty | University of Missouri–St. Louis | 3 |
| 2 | Onome Ugono | University of Missouri–St. Louis | 2 |
| 3 | Annie K. Powell | Karlsruhe Institute of Technology | 2 |
| 4 | Rodolphe Clérac | Centre de recherche Paul Pascal | 2 |
| 5 | Christopher E. Anson | Karlsruhe Institute of Technology | 2 |
| 6 | Shao-Ai Li | Guangdong Province Environmental Monitoring Center | 2 |
| 7 | Xiao‐Ying Huang | Rutgers, The State University of New Jersey | 2 |
| 8 | Philippa King | Karlsruhe Institute of Technology | 2 |
| 9 | Xin‐Hui Zhou | Nanjing University of Posts and Telecommunications | 2 |
| 10 | Ying‐Zhong Shen | Nanjing University of Aeronautics and Astronautics | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Two- and Three-Dimensional Lanthanide Complexes: Synthesis, Crystal Structures, and Properties | 2007 | 284 | Metal-Organic Frameworks: Synthesis and Applications |
| The Effect of pH on the Dimensionality of Coordination Polymers | 2001 | 243 | Metal-Organic Frameworks: Synthesis and Applications |
| Syntheses, structures and fluorescent properties of two novel coordination polymers in the U–Cu–H 3 pdc system | 2005 | 159 | Metal-Organic Frameworks: Synthesis and Applications |
| CO2 selectivity of a 1D microporous adenine-based metal–organic framework synthesised in water | 2011 | 100 | Metal-Organic Frameworks: Synthesis and Applications |
| The building block approach to extended solids: 3,5-pyrazoledicarboxylate coordination compounds of increasing dimensionality | 2004 | 98 | Metal-Organic Frameworks: Synthesis and Applications |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of 1H-pyrazole-3,5-dicarboxylic acid?
Which organizations hold the most patents involving this compound?
What are the primary technological fields associated with patents using this compound?
How has patent filing activity for this compound trended in recent years?
What research topics are associated with published papers on this compound?